After a mean follow-up of @ months , @ patients ( @ % ) achieved DAS@ remission ; @ were randomised to one of two dose regimens : etanercept @ weekly ( group A , @ patients ) and etanercept @ mg bi-weekly ( group B , @ patients ) .